{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-116227","form_type":"8-K","ticker":"ABBV","cik":"0001551152","company_name":"AbbVie Inc.","filed_at":"2026-10-15T20:00:53+00:00","discovered_at":"2026-10-15T20:02:00.285400+00:00","generated_at":"2026-10-15T20:02:06.904400+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"AbbVie expands board to 13, appoints Dr. John M. Carethers as Class II director","bullets":["Board size increased from twelve to thirteen directors on October 14, 2026; Dr. John M. Carethers named a Class II director.","Carethers is Vice Chancellor for Health Sciences at University of California San Diego and was previously a director of Avantor, Inc.","Board determined Carethers is independent under NYSE section 303A.02 and AbbVie's Governance and Director Independence Guidelines.","He was appointed to the Public Policy and Sustainability Committee of the AbbVie board.","Compensation will follow independent-director terms disclosed in Exhibit 10.5 to AbbVie's Form 10-Q for the quarter ended March 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-116227","json":"https://secwatch.observer/filing/0001104659-26-116227.json","markdown":"https://secwatch.observer/filing/0001104659-26-116227.md","text":"https://secwatch.observer/filing/0001104659-26-116227.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551152/000110465926116227/0001104659-26-116227-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551152/000110465926116227/tm2627361d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-15T20:02:06.904400+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}